comparemela.com

Latest Breaking News On - Drugs database - Page 1 : comparemela.com

Top 20 biopharma kick off 9 6% market cap surge in Q1 2024 amid Medicare price talks

GlobalData : TauRx s HMTM could become first oral DMT targeting Tau for Alzheimer s disease, says GlobalData -March 08, 2024 at 11:12 pm EST

08 Mar, 2024 TauRx s HMTM could become first oral DMT targeting Tau for Alzheimer s disease, says GlobalData Share Print.

Otsuka s new formulations to offset Abilify Maintena dual patent expiry impact, says GlobalData - Pharma News

Otsuka s new formulations to offset Abilify Maintena dual patent expiry impact, says GlobalData - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Otsuka s new formulations to offset Abilify Maintena dual patent expiry impact, says GlobalData

Otsuka Pharmaceutical is poised for a strategic transition as it approaches the loss of market exclusivity of Abilify Maintena (Aripiprazole) in Europe and the US in October 2024. This significant development signals a forthcoming shift in the drug’s sales trajectory, highlighting Otsuka’s readiness to embrace .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.